Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BYM Technologies was an Israeli medical technology company that specialized in the development of advanced negative pressure wound therapy (NPWT) solutions. The company is best known for its flagship product, Wound-Ex, a lightweight, portable, and disposable NPWT system designed to treat a variety of chronic and acute wounds. Unlike traditional NPWT devices that relied on heavy, reusable pumps, BYM's technology offered a cost-effective and user-friendly alternative that improved patient mobility and was suitable for both clinical and home care settings. The company's assets and technology were eventually acquired by Medline Industries, which integrated the Wound-Ex product line into its global wound care portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on B.Y.M. Technologies.